Biomatlante SAS products

Building on Biomatlante’s core MBCP Technology, In’Oss™ is an innovative and moldable bone graft, composed of Hydroxyapatite (HA), Beta Tricalcium Phosphate (ß-TCP) and a hydrogel. Developed to facilitate handling3,15 during bone grafting procedures, In’Oss™ can fit into different grafting sites. In’Oss™ keeps the original graft shape and bone volume. It is gradually absorbed to be replaced by vital architectured bone.

MBCP® Syringe is a synthetic bone graft substitute: MBCP® Technology granules in mixing delivery system, ideal for bone reconstruction. This synthetic bone graft substitute in its syringe can be combined with your osteoinductive factor like bone marrow material for bone tissue engineering. It is the adapted synthetic bone graft matrix for tissue engineering.

Ideally, any biocompatible synthetic bone graft substitute material used to replace or augment graft material should become integrated with the surrounding bone tissue and ultimately be replaced by new healthy bone, as seen with autologous graft.